PET Detection of CCR2 in Human Atherosclerosis

PET Detection of CCR2 in Human Atherosclerosis

ConditionCarotid Atherosclerosis

Trial statusRecruiting

Trial phasePhase 1

Trial typeInterventional

Biological sexAll

Age18-89

SponsorWashington University School of Medicine

About this trial

: Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial atherosclrosis

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine)
Group 2 64CU-DOTA-ECL1i (radioactive imaging medicine)

Treatment groups

100 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Washington University School of Medicine